Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacMILLAN, A. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MacMILLAN, A. E.
(Chest. 1947;13:686-688.)
© 1947 American College of Chest Physicians

Heparin in Empyema

Report of a Case

ANGUS E. MacMILLAN M.D., F.C.C.P.

Few conclusions can be drawn from one case but it does seem that heparin can safely be used in the pleural cavity without effecting the blood coagulation time of the patient. Guernar Bauer2 in his splendid article "Heparin in Venous Thrombosis," reported on the use of very large doses of heparin intravenously without any ill effects. Lehman and Boys3 injected 120 cc. of heparin in the abdomen following operations to prevent adhesions. Undoubtedly much larger amounts of heparin can safely be used in empyema cases than was used in the case just reported and allowed to remain longer before being withdrawn. It may also be to advantage to use it soon after the infection appears with a view of preventing adhesions which anchor the lung and retard or prevent its expansion.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1947 by the American College of Chest Physicians.